People · Operator
Named in public records as an officer, director or promoter · active 2010–2010 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| China Medicine Corp | — | Pharmaceuticals | Series C | $69.6M | $2.4B | 2010 |
Yangfang Chen at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Yangfang Chen on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Sean Shao | 1 | 3 |
| Robert Adler | 1 | 3 |
| Robert Lu | 1 | 2 |
| Daniel Shih | 1 | 1 |
| Ryan Shih | 1 | 1 |
| Senshan Yang | 1 | 1 |
| Ian Grant Robinson | 1 | 1 |
| Rachel Gong | 1 | 1 |
| Fred Cheung | 1 | 1 |
| Minhua Liu | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.